pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pyridostigmine bromide 180 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-220
Product ID 64980-220_34812796-3684-4619-a70c-fc93e22d123a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205464
Listing Expiration 2026-12-31
Marketing Start 2017-08-15

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980220
Hyphenated Format 64980-220

Supplemental Identifiers

RxCUI
903847
UPC
0364980220033
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA205464 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (64980-220-03)
source: ndc

Packages (1)

Ingredients (1)

pyridostigmine bromide (180 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "34812796-3684-4619-a70c-fc93e22d123a", "openfda": {"upc": ["0364980220033"], "unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["f7a75639-a23a-4847-a962-c091c61947f0"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (64980-220-03)", "package_ndc": "64980-220-03", "marketing_start_date": "20170815"}], "brand_name": "Pyridostigmine Bromide", "product_id": "64980-220_34812796-3684-4619-a70c-fc93e22d123a", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "64980-220", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "ANDA205464", "marketing_category": "ANDA", "marketing_start_date": "20170815", "listing_expiration_date": "20261231"}